Researchers prevent mice from developing diabetes

Researchers prevent mice from developing diabetes
Macrophages. Copyright: Roham Parsa

(Medical Xpress) -- Swedish research group headed at Karolinska Institutet has been able to prevent onset of Type 1 diabetes in mice that are genetically susceptible to the disease. Through injection of specifically prepared cells, the researchers managed to stop the ongoing destruction of insulin-producing pancreatic beta cells in mice just prior to clinical debut of diabetes.

Type 1 is an autoimmune disease in which the immune system begins to attack and destroy the insulin-producing . This leads to a deficiency in production of insulin, which individuals with Type 1 diabetes thereafter have to inject. The initial cause of this autoimmune destruction is currently not known.

However, it is known that , a particular type of immune cells, have an active role in the destruction of in Type 1 diabetes. Yet macrophages can also exhibit the opposite properties; earlier studies have demonstrated that macrophages can protect against inflammation-mediated tissue damage.

utilise signal molecules termed cytokines in order to communicate with each other, giving instructions as to how the cells should act. In the current article, published in the scientific journal Diabetes, the researchers aimed to determine which cytokines were necessary to instruct macrophages to become protective cells.

"We managed to achieve this aim, defining a novel combination of cytokines that confer on macrophages the ability to protect mice from developing Type 1 diabetes", says Robert Harris, lead researcher at the Department of Clinical Neuroscience and based at the Centre for , Karolinska Institutet. "It has never previously been reported, that such an adoptive transfer cell therapy can be used in Type 1 diabetes and this study could thus represent a major advance towards disease prevention"

The researchers used so-called NOD mice which are genetically susceptible to developing Type 1 diabetes spontaneously between 12-30 weeks of age. The researchers grew macrophages from bone marrow progenitors from these mice. The mature macrophages were then stimulated with the defined combination of cytokines. When NOD mice were 16 weeks old separate groups were treated with either cytokine-stimulated macrophages, untreated macrophages of were not treated.

The mice were monitored for a further 12 weeks post-treatment. Using a specific three-dimensional imaging technique developed at Umeå University, Sweden, the degree of immune-mediated attack of the beta cells could be visualized in each treatment group. At the end of the follow-up period only 25% of the mice receiving the cytokine-treated macrophages had developed Type 1 diabetes, while 83% of the control groups had become sick.

"The cell therapy was initiated just 2 weeks before mice developed clinical diabetes", says Dr Harris. "At this stage few insulin-producing beta cells remain in the pancreas, yet we were able to protect these so that the mice never developed diabetes. Such a successful late-stage intervention has never previously been reported and is a significant result of our study. At the time of their clinical diagnosis, most human individuals have already lost most of their insulin-producing beta cells."

Related Stories

Gene therapy reverses type 1 diabetes in mice

Jun 06, 2011

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of ...

Gene therapy reverses type 1 diabetes in mice

Jun 21, 2010

Researchers have developed an experimental cure for Type 1 diabetes, a disease that affects about one in every 400 to 600 children and adolescents. They will present their results in a mouse model of Type 1 diabetes on Sunday ...

Recommended for you

Economic burden of prediabetes up 74 percent over five years

Nov 20, 2014

The economic burden of diabetes in America continues to climb, exceeding more than $322 billion in excess medical costs and lost productivity in 2012, or more than $1,000 for every American, according to a study being published ...

Gynoid fat resists metabolic risks of obesity

Nov 19, 2014

(HealthDay)—The differences in the developmental profiles of upper-body and lower-body fat depots may explain their opposing associations with obesity-related metabolic disease, according to research published ...

Treating diabetes one meal at a time

Nov 19, 2014

Recent estimates project that as many as one in three American adults will have diabetes in 2050. The American Diabetes Association observes November as American Diabetes Month, and this year's theme is America ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.